Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Read More Pharma Industry News ESTEVE acquires Caprelsa from Sanofi to boost rare cancer drug portfolio and global specialty focus ESTEVE is acquiring Caprelsa® from Sanofi to expand its rare cancer drug portfolio. The deal boosts ESTEVE's focus on highly specialized treatments. byPallavi MadhirajuJuly 2, 2025